Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
CD20 expression + PAX5 expression + BCL2 expression
i
Other names:
CD20, MS4A1, Membrane Spanning 4-Domains A1, Membrane-Spanning 4-Domains, Subfamily A, Member 1, Leukocyte Surface Antigen Leu-16, B-Lymphocyte Antigen CD20, CD20 Antigen, Membrane-Spanning 4-Domains Subfamily A Member 1, B-Lymphocyte Cell-Surface Antigen B1, B-Lymphocyte Surface Antigen B1, CD20 Receptor, LEU-16, CVID5, MS4A2
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
596
;
494216
;
5079
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
CD20 positive (50)
BCL2 overexpression (17)
BCL2 expression (9)
BCL2 expression + MYC expression (8)
CD20 expression (8)
BCL2 positive (7)
MYC overexpression + BCL2 overexpression (7)
CD20 overexpression (5)
CD20 underexpression (3)
BCL2 overexpression + MCL1 overexpression (2)
BCL2 underexpression (2)
MYC expression + BCL2 expression (2)
CD19 positive + CD20 positive (2)
CD20 negative (2)
PAX5 overexpression (2)
BCL2 overexpression + CCND1 overexpression (1)
BCL2 overexpression + MCL1 expression (1)
BCL2 overexpression + MCL1 underxpression + BCL2L1 underexpression (1)
BCL2 overexpression + MYC overexpression (1)
BCL2 positive + LGALS3 expression (1)
BTK expression + BCL2 expression (1)
BTK expression + BCL2 expression + MYC expression (1)
CASP3 overexpression + BCL2 negative (1)
CASP3 underexpression + BCL2 positive (1)
CD22 underexpression + BCL2 overexpression (1)
MYC expression + BCL2 expression + BCL6 expression (1)
MYC positive + BCL2 positive (1)
MYC positive + BCL2 positive + BCL6 positive (1)
CD19 negative + CD20 negative + CD22 negative (1)
CD20 expression + TNFRSF8 overexpression (1)
CD20 positive + MME positive + TNFRSF8 negative (1)
BCL2 positive + IGH positive (0)
CD20 positive (50)
BCL2 overexpression (17)
BCL2 expression (9)
BCL2 expression + MYC expression (8)
CD20 expression (8)
BCL2 positive (7)
MYC overexpression + BCL2 overexpression (7)
CD20 overexpression (5)
CD20 underexpression (3)
BCL2 overexpression + MCL1 overexpression (2)
BCL2 underexpression (2)
MYC expression + BCL2 expression (2)
CD19 positive + CD20 positive (2)
CD20 negative (2)
PAX5 overexpression (2)
BCL2 overexpression + CCND1 overexpression (1)
BCL2 overexpression + MCL1 expression (1)
BCL2 overexpression + MCL1 underxpression + BCL2L1 underexpression (1)
BCL2 overexpression + MYC overexpression (1)
BCL2 positive + LGALS3 expression (1)
BTK expression + BCL2 expression (1)
BTK expression + BCL2 expression + MYC expression (1)
CASP3 overexpression + BCL2 negative (1)
CASP3 underexpression + BCL2 positive (1)
CD22 underexpression + BCL2 overexpression (1)
MYC expression + BCL2 expression + BCL6 expression (1)
MYC positive + BCL2 positive (1)
MYC positive + BCL2 positive + BCL6 positive (1)
CD19 negative + CD20 negative + CD22 negative (1)
CD20 expression + TNFRSF8 overexpression (1)
CD20 positive + MME positive + TNFRSF8 negative (1)
BCL2 positive + IGH positive (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
CD20 expression + PAX5 expression + BCL2 expression
Marginal Zone Lymphoma
CD20 expression + PAX5 expression + BCL2 expression
Marginal Zone Lymphoma
rituximab
Sensitive: C4 – Case Studies
rituximab
Sensitive
:
C4
rituximab
Sensitive: C4 – Case Studies
rituximab
Sensitive
:
C4
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.